5-hydroxydecanoate has been researched along with Pulmonary Hypertension in 2 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, L | 1 |
| Li, Y | 2 |
| Hu, H | 1 |
| Shi, L | 1 |
| Chen, J | 1 |
| Wang, B | 1 |
| Chen, C | 2 |
| Zhu, H | 1 |
| Li, Q | 2 |
| Zhang, L | 1 |
| Shu, Y | 1 |
| Li, YL | 1 |
| Zhang, LP | 1 |
| Chen, CS | 1 |
2 other studies available for 5-hydroxydecanoate and Pulmonary Hypertension
| Article | Year |
|---|---|
Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension.
Topics: Animals; Blood Pressure; Cell Proliferation; Chemokine CCL2; Decanoic Acids; Hydroxy Acids; Hyperten | 2014 |
[The effect of 5-HD on expression of PKC-alpha in rats of chronic hypoxic pulmonary hypertension].
Topics: Animals; Decanoic Acids; Hydroxy Acids; Hypertension, Pulmonary; Hypoxia; Male; Muscle, Smooth, Vasc | 2011 |